NPI: 1700211083 · LAREDO, TX 78040 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/05/2013
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 09/05/2013 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 5,848 | $4K |
| 2022 | 2,822 | $4K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 134 | 26 | $8K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 6,072 | 438 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 17 | 17 | $0.00 |
| 83550 | 217 | 215 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 474 | 414 | $0.00 |
| 82728 | 217 | 215 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 111 | 85 | $0.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 68 | 12 | $0.00 |
| 85048 | 391 | 383 | $0.00 | |
| 83970 | 226 | 190 | $0.00 | |
| 83540 | 217 | 215 | $0.00 | |
| 82108 | 120 | 120 | $0.00 | |
| 85041 | 406 | 397 | $0.00 |